Suk Y - Search Results

1

Overview Of The Canadian Clinician Investigator Trainees' Research Presented At The 2020 CSCI-CITAC Joint Meeting.

Castanov V, Phuong M, Bogie BJM, Jomaa D, LeBlanc EV, Macklin J, Saint-Georges Z, Suk Y, Wang W, Ware MA, Whittaker HT, Pietrobon A. Castanov V, et al. Among authors: suk y. Clin Invest Med. 2021 Oct 3;44(3):E4-10. doi: 10.25011/cim.v44i3.37245. Clin Invest Med. 2021. PMID: 34600455

2

AMPK Promotes Xenophagy through Priming of Autophagic Kinases upon Detection of Bacterial Outer Membrane Vesicles.

Losier TT, Akuma M, McKee-Muir OC, LeBlond ND, Suk Y, Alsaadi RM, Guo Z, Reshke R, Sad S, Campbell-Valois FX, Gibbings DJ, Fullerton MD, Russell RC. Losier TT, et al. Among authors: suk y. Cell Rep. 2019 Feb 19;26(8):2150-2165.e5. doi: 10.1016/j.celrep.2019.01.062. Cell Rep. 2019. PMID: 30784596 Free article.

3

[No title available]

[No authors listed] [No authors listed] PMID: 39325578

4

Childhood Medulloblastoma: An Overview.

Suk Y, Gwynne WD, Burns I, Venugopal C, Singh SK. Suk Y, et al. Methods Mol Biol. 2022;2423:1-12. doi: 10.1007/978-1-0716-1952-0_1. Methods Mol Biol. 2022. PMID: 34978683 Review.

5

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK, Qazi MA, Vora P, Kameda-Smith MM, Savage N, Desmond KL, Tatari N, Tran D, Seyfrid M, Hope K, Bock NA, Venugopal C, Bader GD, Singh SK. Bakhshinyan D, et al. Among authors: suk y. Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8. Sci Adv. 2021. PMID: 34878832 Free PMC article.

6

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

Nawar N, Bukhari S, Adile AA, Suk Y, Manaswiyoungkul P, Toutah K, Olaoye OO, Raouf YS, Sedighi A, Garcha HK, Hassan MM, Gwynne W, Israelian J, Radu TB, Geletu M, Abdeldayem A, Gawel JM, Cabral AD, Venugopal C, de Araujo ED, Singh SK, Gunning PT. Nawar N, et al. Among authors: suk y. J Med Chem. 2022 Feb 24;65(4):3193-3217. doi: 10.1021/acs.jmedchem.1c01585. Epub 2022 Feb 4. J Med Chem. 2022. PMID: 35119267

7

The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues.

Burns I, Gwynne WD, Suk Y, Custers S, Chaudhry I, Venugopal C, Singh SK. Burns I, et al. Among authors: suk y. Front Oncol. 2022 Jan 27;12:815726. doi: 10.3389/fonc.2022.815726. eCollection 2022. Front Oncol. 2022. PMID: 35155252 Free PMC article.

8

Derivation and culturing of neural stem cells from human embryonic brain tissue.

Suk Y, Kieliszek A, Mobilio D, Venugopal C, Singh SK. Suk Y, et al. STAR Protoc. 2022 Aug 18;3(3):101628. doi: 10.1016/j.xpro.2022.101628. eCollection 2022 Sep 16. STAR Protoc. 2022. PMID: 36035806 Free PMC article.

9

Safety and efficacy of lorlatinib against ALK-driven refractory or relapsed neuroblastoma.

Suk Y, Singh SK. Suk Y, et al. Cell Rep Med. 2023 Jun 20;4(6):101071. doi: 10.1016/j.xcrm.2023.101071. Cell Rep Med. 2023. PMID: 37343514 Free PMC article.

10

Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.

Buchan TA, Malik A, Chan C, Chambers J, Suk Y, Zhu JW, Ge FZ, Huang LM, Vargas LA, Hao Q, Li S, Mustafa RA, Vandvik PO, Guyatt G, Foroutan F. Buchan TA, et al. Among authors: suk y. Heart. 2021 Dec;107(24):1962-1973. doi: 10.1136/heartjnl-2021-319243. Epub 2021 Apr 8. Heart. 2021. PMID: 33833070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters